Alpha 2.0
Login Register
» Articles » PMID: 15102972

Two Haemodialysis Patients with Epoetin Alfa-induced Pure Red-cell Aplasia Recovered Despite Treatment with Another Epoetin Preparation

Overview
Journal Nephrol Dial Transplant
Publisher Oxford University Press
Specialties General Surgery
Nephrology
Date 2004 Apr 23
PMID 15102972
Citations 4
Authors
Aarne Vartia
Markku R Asola
Risto Tertti
Pertti Kunelius
Kaj P Metsarinne
Affiliations
Soon will be listed here.
Citing Articles

Pure red cell aplasia due to antibody against erythropoietin in hemodialysis patients.

Rahbar M, Chitsazian Z, Abdoli F, Moeini Taba S, Akbari H J Nephropathol. 2017; 6(1):25-29.

PMID: 28042550 PMC: 5106879. DOI: 10.15171/jnp.2017.05.

Improvement in erythropoieis-stimulating agent-induced pure red-cell aplasia by introduction of darbepoetin-α when the anti-erythropoietin antibody titer declines spontaneously.

Lee H, Yang J, Kim H, Kwon J, Oh K, Joo K J Korean Med Sci. 2010; 25(11):1676-9.

PMID: 21060762 PMC: 2967010. DOI: 10.3346/jkms.2010.25.11.1676.

Anti-erythropoietin antibodies followed by endogenous erythropoietin production in a dialysis patient.

Mattison P, Upadhyay K, Wilcox J, Moudgil A, Silverstein D Pediatr Nephrol. 2010; 25(5):971-6.

PMID: 20091055 DOI: 10.1007/s00467-009-1406-4.

Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project.

Bennett C, Cournoyer D, Carson K, Rossert J, Luminari S, Evens A Blood. 2005; 106(10):3343-7.

PMID: 16099877 PMC: 1895064. DOI: 10.1182/blood-2005-02-0508.